SLU-PP-332 Powder is a chemical powder, also known as 4-hydroxy-N '- (naphthalen-2-ylmethylene) benzoyl hydrazine, mainly composed of SLU-PP-332, which is a biologically active compound and belongs to the group of estrogen receptor related receptor (ERR) agonists. The appearance is generally white to off white. It is a pan estrogen receptor related receptor (ERR) agonist with high affinity for ERR α, ERR β, and ERR γ. Its EC50 values are 98 nM, 230 nM, and 430 nM, respectively, indicating that it has the highest affinity for ERR α. It can enhance the mitochondrial function and cellular respiration of skeletal muscle cell lines, which helps to improve the energy metabolism efficiency of cells. This substance usually needs to be stored under low temperature, dark, and dry conditions to maintain its stability and activity.
Our product
SLU-PP-332 COA
SLU-PP-332 Powder, as a chemical substance with special biological activity, has received widespread attention in the field of scientific research in recent years. Its unique chemical structure and mechanism of action make it exhibit potential application value in multiple aspects. The following is a detailed explanation of its purpose:
Application in scientific research
Application in cell experiments
In cell experiments, SLU-PP-332 is often used to construct specific cell models to study the function and mechanism of action of ERR receptors in cells. For example, when studying the effect of ERR receptors on muscle cell metabolism, researchers can add SLU-PP-332 to cultured muscle cells. By observing the cellular response to SLU-PP-332, such as changes in mitochondrial function and fatty acid oxidation rate, we can gain a deeper understanding of the role of ERR receptors in muscle cell energy metabolism. In addition, SLU-PP-332 can also be used to construct other types of cell models, such as adipocyte models, liver cell models, etc., to study the function and regulatory mechanisms of ERR receptors in different cell types.
The construction of these cell models provides an important experimental platform for in-depth study of the physiological and pathological roles of ERR receptors.SLU-PP-332 can affect the activity of these signaling pathways by activating ERR receptors, thereby regulating processes such as cell growth, proliferation, differentiation, and metabolism. Researchers can use SLU-PP-332 as a tool compound to investigate the interactions between ERR receptors and these signaling pathways.
Custom Notebook Solutions
For example, by detecting the expression levels and phosphorylation status of intracellular signaling molecules after treatment with SLU-PP-332, the regulatory mechanism of ERR receptors on signaling pathways can be revealed. This research helps us to gain a deeper understanding of the signaling network within cells, providing a theoretical basis for the discovery of the mechanisms and therapeutic targets of related diseases. SLU-PP-332 also has important applications in the study of cell proliferation and differentiation. The ERR receptor plays a crucial regulatory role in the process of cell proliferation and differentiation. After activating the ERR receptor, SLU-PP-332 can affect the cell cycle progression and promote or inhibit cell proliferation. For example, in certain tumor cells, abnormal expression of ERR receptors may be closely related to the occurrence and development of tumors.
Researchers can use SLU-PP-332 to investigate the role of ERR receptors in tumor cell proliferation and explore the possibility of inhibiting tumor cell growth by regulating ERR receptor activity. In addition, SLU-PP-332 can also affect the differentiation direction of cells. In stem cell research, the addition of SLU-PP-332 can induce stem cells to differentiate into specific cell types, providing a new approach for tissue engineering and regenerative medicine.
Application in animal experiments
In animal experiments, SLU-PP-332 Powder can be used to construct specific animal models to simulate human physiological or pathological states, and to study the function and mechanism of action of ERR receptors at the overall animal level. For example, when studying the relationship between ERR receptor and metabolic diseases, researchers can inject a certain dose of SLU-PP-332 into mice to induce pathological changes of metabolic diseases such as obesity and diabetes.
By observing and analyzing these animal models, we can gain a deeper understanding of the role of ERR receptors in metabolic regulation, as well as the impact of SLU-PP-332 on the occurrence and development of these diseases. In addition, SLU-PP-332 can also be used to construct other types of animal models, such as muscle atrophy models, neurodegenerative disease models, etc., providing powerful tools for the study of related diseases.
Application in animal experiments
In the process of drug development, SLU-PP-332 Powder is often used to evaluate the efficacy and safety of drugs. Researchers can combine the tested drug with SLU-PP-332 to observe the effects of the drug on the physiological or pathological changes induced by SLU-PP-332. For example, when studying a new type of weight loss drug, the drug can be administered to obese mice simultaneously with SLU-PP-332 to observe whether the drug can enhance or weaken the weight loss effect of SLU-PP-332, in order to evaluate the efficacy of the drug.
At the same time, it is necessary to monitor whether the drug will cause adverse reactions during use, such as changes in animal behavior, organ damage, etc., in order to evaluate the safety of the drug. Through this animal experimental method, important data support can be provided for preclinical research of drugs, reducing the risks of drug development.
Application in animal experiments
SLU-PP-332 can also be used in animal experiments to further investigate physiological and pathological mechanisms. ERR receptors play important roles in multiple physiological processes of the body, such as energy metabolism, reproductive development, and immune regulation. By administering SLU-PP-332 to animals, the impact of changes in ERR receptor activity on these physiological processes can be observed, thereby revealing the physiological functions of ERR receptors. For example, when studying the effects of ERR receptors on the reproductive system, female mice can be injected with SLU-PP-332 to observe its effects on the estrous cycle, reproductive organ development, and reproductive ability of mice. In addition, in terms of pathological mechanism research, SLU-PP-332 can be used to investigate the role of ERR receptors in disease occurrence and development.
For example, when studying cardiovascular diseases, SLU-PP-332 can induce cardiovascular pathological changes in animals, observe the role of ERR receptors in these changes, and provide new targets for the treatment of cardiovascular diseases.
Application in metabolic disease research
Obesity research
In obesity research, SLU-PP-332 has shown significant effects. Research has shown that intraperitoneal injection of SLU-PP-332 (50 mg/kg, twice daily, for 28 or 12 days) into obese mice can induce fatty acid metabolism, reduce fat mass, and improve glucose metabolism in a diet induced obese mouse model. From the perspective of its mechanism of action, SLU-PP-332 regulates gene expression related to fat metabolism and energy balance by activating the ERR receptor.
For example, it may promote the oxidative decomposition of fatty acids, increase energy consumption, and thus reduce fat accumulation.At the same time, it may also improve insulin sensitivity, promote glucose uptake and utilization, and help lower blood sugar levels. These research results indicate that SLU-PP-332 has potential application value in the treatment of obesity, which may provide new ideas for the development of novel obesity treatment drugs.
Diabetes Research
SLU-PP-332 has also received some attention in the research of diabetes. Although there are relatively few direct studies on its role in the treatment of diabetes at present, it can be speculated that it may play a role in improving insulin resistance and regulating blood glucose level based on its activation of ERR receptor and its regulatory function on metabolism. ERR receptors play an important regulatory role in energy metabolism and insulin signaling.
By activating these receptors, SLU-PP-332 may enhance insulin sensitivity, promote glucose uptake and utilization, and thus lower blood glucose levels. In addition, it may also regulate fat metabolism, reduce fat accumulation in organs such as the liver, and improve the pathophysiological basis of insulin resistance. Future research can further explore the specific mechanism and efficacy of SLU-PP-332 in the treatment of diabetes, and provide more scientific basis for its application in the field of diabetes.
Research on metabolic syndrome
Metabolic syndrome is a group of metabolic disorders characterized by obesity, hypertension, hyperglycemia, and dyslipidemia. SLU-PP-332 also has potential application value in the study of metabolic syndrome. Due to its ability to reduce fat mass and improve insulin sensitivity, SLU-PP-332 may have a positive impact on multiple aspects of metabolic syndrome. For example, it can reduce the risk of cardiovascular disease by regulating fat metabolism, lowering blood lipid levels. At the same time, improving insulin sensitivity is helpful to control blood sugar level and alleviate the symptoms of diabetes.
In addition, SLU-PP-332 may also have a certain impact on blood pressure regulation, further improving the overall condition of metabolic syndrome. However, the application of SLU-PP-332 in metabolic syndrome research is still in its preliminary stage, and more research is needed to confirm its specific role and efficacy.
As a high‑purity raw material powder, SLU‑PP‑332 requires a stable, sensitive, and specific analytical method for purity testing, assay, related substances testing, and uniformity evaluation to meet the requirements of research and development, production, and quality control.
I. Description and Preliminary Identification
Appearance: white or almost white powder, odorless, slightly hygroscopic.Preliminary identification can be performed by ultraviolet spectrophotometry. In ethanol or acetonitrile solution, it exhibits a maximum absorption at a characteristic wavelength, consistent with the spectrum of the reference standard. This allows rapid identification of authenticity and contamination.
II. Assay (HPLC Method)
The quantitative analysis is performed by high‑performance liquid chromatography.Column: octadecylsilyl‑bonded silica gel.Mobile phase: acetonitrile‑water, using gradient or isocratic elution.Detection wavelength: characteristic absorption wavelength.
Appropriate amounts of reference standard and test sample are dissolved, diluted, and injected. The chromatogram is recorded, and the content is calculated from the peak area by the external standard method.The content of SLU‑PP‑332 powder shall be not less than 98.0%.This method shows high specificity, good repeatability, and high accuracy.
III. Related Substances Testing
The same HPLC system is used. Related substances are determined by the principal component self‑control method or area normalization method.The limits for the largest single impurity and total impurities are controlled to effectively monitor synthetic residues, degradation products, and process impurities, ensuring the stability and safety of the powder.
IV. Water and Residual Solvents Testing
Water content is determined by Karl Fischer method to ensure the stability of the powder.Residual solvents are tested by gas chromatography to comply with the limits for pharmaceutical raw materials, providing stable raw material support for subsequent preparation production.
FAQ
1. What is SLU-PP-332 powder?
+
-
SLU-PP-332 is a novel small molecule compound currently in the preclinical research stage and is designed as a "motion simulator". It specifically activates key metabolic regulatory proteins within cells (such as ERRγ), thereby mimicking the positive effects of exercise on energy metabolism and muscle function without the need for physical exercise.
2. What are the main research goals and potential application directions?
+
-
The core research objective is to combat muscle atrophy and metabolic diseases. Potential applications include: treating muscle loss caused by aging, cancer, heart failure, or prolonged bed rest; improving the metabolic health of obese and type 2 diabetic patients; and serving as a tool molecule for studying energy metabolism.
3. What stage is it currently in? Can the public access and use it?
+
-
Currently, only animal experiments (on mice) have been conducted, showing effects such as increased endurance, reduced fat, and enhanced muscle strength. No human clinical trials have been carried out yet, and its safety and effectiveness are far from being clear. Therefore, it is only used as a strictly controlled research chemical, for laboratory research purposes only, and is absolutely not sold as a consumer product or medicine.
4. What are the main risks and controversies?
+
-
The greatest risk is the unknown long-term toxicity, including potential effects on the heart, liver and other organs. The scientific community is cautious about whether it can truly safely "simulate exercise", fearing that it might disrupt the delicate physiological balance. Any non-research-related attempts are extremely risky to health and illegal.
Hot Tags: slu-pp-332 powder, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Melanotan ii powder, dermorphin in humans, Cosmetic, DERMORPHIN, dermorphin peptide